✦ LIBER ✦

448 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN REDUCES DURATION IN NAIVE AND PEGINTERFERON ALFA-2B/RIBAVIRIN PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV GENOTYPE 1

✍ Scribed by M.P. Manns; F. Poordad; B.R. Bacon; S. Bruno; R. Esteban; M. Silva; M. Buti; M. Burroughs; V. Sniukiene; N. Boparai; C.A. Brass; J.K. Albrecht; J.-P. Bronowicki

Book ID: 117379593
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 114 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(11)60450-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

481 FOUR-WEEK THERAPY WITH PEGINTERFERON

481 FOUR-WEEK THERAPY WITH PEGINTERFERON ALFA-2B/ RIBAVIRIN EFFECTIVELY PREDICTS SUSTAINED VIROLOGIC RESPONSE IN TREATMENT-NAIVE AND PREVIOUS-TREATMENT-FAILURE PATIENTS WITH HCV-1 TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

✍ J.M. Vierling; E.J. Lawitz; F. Poordad; M.S. Sulkowski; M. Bourliere; M. Buti; C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

452 EFFICACY AMONG NORTH AMERICAN AND EU

452 EFFICACY AMONG NORTH AMERICAN AND EUROPEAN HCV GENOTYPE-1 TREATMENT-NAIVE AND PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

✍ P. Marcellin; J.M. Vierling; L. Alric; M. Pirisi; A. Tran; J.K. Albrecht; C.A. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

484 PREDICTORS OF SUSTAINED VIROLOGIC RE

484 PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE AMONG GENOTYPE 1 PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN RE-TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

✍ S. Zeuzem; J.M. Vierling; R. Esteban; A.L. Gibas; S. Pol; N. Boparai; M. Burroug 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

56 ON-TREATMENT RESPONSE-GUIDED THERAPY

56 ON-TREATMENT RESPONSE-GUIDED THERAPY WITH TELAPREVIR Q8H OR Q12H COMBINED WITH PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B AND RIBAVIRIN IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C (STUDY C208)

✍ X. Forns; P. Marcellin; P. Ferenci; T. Göser; F. Nevens; G. Carosi; J.P. Drenth; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Early virologic response to treatment wi

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

✍ Gary L. Davis; John B. Wong; John G. McHutchison; Michael P. Manns; Joann Harvey 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

428 ADHERENCE TO ASSIGNED DOSING REGIMEN

428 ADHERENCE TO ASSIGNED DOSING REGIMEN AND SUSTAINED VIROLOGIC RESPONSE AMONG HEPATITIS C GENOTYPE 1 TREATMENT-NAIVE AND PEG/RIBAVIRIN TREATMENT-FAILURES TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN

✍ S.C. Gordon; E.J. Lawitz; B.R. Bacon; M.S. Sulkowski; E.M. Yoshida; M. Davis; N. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 178 KB